Intellicheck (NYSE:IDN – Get Free Report) and iCoreConnect (NASDAQ:ICCT – Get Free Report) are both small-cap industrials companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk.
Profitability
This table compares Intellicheck and iCoreConnect’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Intellicheck | -3.37% | -1.59% | -1.23% |
| iCoreConnect | -263.12% | -1,451.73% | -171.32% |
Risk & Volatility
Intellicheck has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, iCoreConnect has a beta of -1.46, suggesting that its share price is 246% less volatile than the S&P 500.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Intellicheck | $20.66 million | 4.99 | -$1.98 million | ($0.04) | -128.75 |
| iCoreConnect | $11.05 million | 0.01 | -$15.55 million | ($63.20) | 0.00 |
Intellicheck has higher revenue and earnings than iCoreConnect. Intellicheck is trading at a lower price-to-earnings ratio than iCoreConnect, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Intellicheck and iCoreConnect, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Intellicheck | 0 | 0 | 3 | 0 | 3.00 |
| iCoreConnect | 0 | 0 | 0 | 0 | 0.00 |
Intellicheck currently has a consensus price target of $6.1667, indicating a potential upside of 19.74%. Given Intellicheck’s stronger consensus rating and higher possible upside, equities analysts plainly believe Intellicheck is more favorable than iCoreConnect.
Institutional & Insider Ownership
42.8% of Intellicheck shares are owned by institutional investors. Comparatively, 13.4% of iCoreConnect shares are owned by institutional investors. 6.9% of Intellicheck shares are owned by insiders. Comparatively, 59.4% of iCoreConnect shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Intellicheck beats iCoreConnect on 12 of the 14 factors compared between the two stocks.
About Intellicheck
Intellicheck, Inc., a technology company, provides on-demand digital identity validation solutions for KYC, fraud, and age verification needs in North America. The company offers solutions for digital and physical identities for financial services, fintech companies, BNPL providers, e-commerce and retail commerce businesses, law enforcement, and government agencies. It provides identity systems products, including commercial identification products, such as Intellicheck Platform, an identity solution that checks whether an ID is valid, matches the ID to the person presenting it, and provides a risk score to determine the risk of doing business with that person; IDN-Portal, an Intellicheck-branded identity validation application that provides the ability to scan an ID using a mobile phone; IDN-Portal+ that offers document validation, retail POS integration, additional data for analytics and analysis, and online validation, and other features; IDN-Direct that provides access to additional data and the ability to use the platform's Risk Score capability to help with decision-making; and Intellicheck mobile app, which provides the ability to login and scan an ID. The company also offers State Aware Software solution, which provides or restricts information that is electronically scanned from an ID based on the electronic reading laws according to the state in which the ID is scanned; data collection devices that enable its software applications to be used on a variety of commercially available credit card terminals, PDAs, tablets, laptops, desktops, mobile phones, and point-of-sale terminals; and instant credit application kiosk software applications. It serves government, military, and commercial markets. The company was formerly known as Intellicheck Mobilisa, Inc. and changed its name to Intellicheck, Inc. in May 2017. Intellicheck, Inc. was incorporated in 1994 and is headquartered in Melville, New York.
About iCoreConnect
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.
Receive News & Ratings for Intellicheck Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellicheck and related companies with MarketBeat.com's FREE daily email newsletter.
